CrossRef Honeysuckle anthocyanin supplementation prevents diet-induced obesity in C57BL/6 mice Tao Wu, Zhuoping Yu, Qiong Tang, Haizhao Song, Zichun Gao, Wei Chen, Xiaodong Zheng Food & Function.2013
However, it may take a few months to see the full results of Semaglutide
2014: the FDA approved liraglutide 3.0 mg (Saxenda) for chronic weight management the first GLP-1 drug with an obesity indication
(As of August 2024, only one dose of Wegovy is in short supply
Bacteriostatic water contains preservative that prevents bacterial growth in the reconstituted solution, essential for multi-dose vials that you'll access repeatedly over weeks
Those on the highest dosage lost an impressive 20.9% of body weight during clinical trials